LifePoint Hospitals Announces Extension of Consent Solicitation Relating to Its 6.625% Senior Notes Due 2020 (CUSIP No. 53219L AK5)

LifePoint Hospitals Announces Extension of Consent Solicitation Relating to Its 6.625% Senior Notes Due 2020 (CUSIP No. 53219L AK5)

LifePoint Hospitals, Inc. (NASDAQ: LPNT) announced today that it is extending the expiration date of its previously announced consent solicitation (the “Consent Solicitation”) seeking consents from holders of its $400 million outstanding principal amount of 6.625% Senior Notes due 2020 (the “Notes”) for amendments to certain provisions of the indenture governing the Notes.

The Consent Solicitation, which was previously scheduled to expire at 5:00 p.m., New York City time, on August 12, 2013, will be extended to 5:00 p.m., New York City time, on August 15, 2013, unless further extended or terminated by the Company.

All other terms and conditions of the Consent Solicitation, as set forth in the Consent Solicitation Statement dated July 30, 2013 (the “Consent Solicitation Statement”), remain the same.

Copies of the Consent Solicitation Statement and the consent form may be obtained by holders of the Notes from the Information and Tabulation Agent for the Consent Solicitation, D.F. King & Co., Inc., at (800) 949-2583 (toll-free), (212) 269-5550 (collect) or by email: .

Barclays Capital Inc. is the Solicitation Agent for the Consent Solicitation. Questions may be directed to Barclays Capital Inc. at (800) 438-3242 (toll-free) or (212) 528-7581 (collect).

LifePoint Hospitals, Inc. is a leading hospital company focused on providing quality healthcare services close to home. Through its subsidiaries, LifePoint operates 57 hospital campuses in 20 states. With a mission of “Making Communities Healthier®,” LifePoint is the sole community hospital provider in the majority of the communities it serves. More information about the Company, which is headquartered in Brentwood, Tennessee, can be found on its website, . All references to “LifePoint,” “LifePoint Hospitals,” or the “Company” used in this release refer to LifePoint Hospitals, Inc. or its affiliates.